Used in research settings to quantify mid-regional pro-adrenomedullin (MR-proADM) levels in human plasma or serum samples. This immunoassay kit enables assessment of adrenomedullin precursor peptides, which are biomarkers associated with cardiovascular function, sepsis severity, endothelial activation, and inflammatory responses. Commonly applied in clinical studies to evaluate disease progression in heart failure, septic shock, and critical illness. Provides a reliable and sensitive tool for monitoring MR-proADM as a prognostic indicator in acute and chronic conditions involving vascular stress.